Jiří Masopust

799 total citations
45 papers, 570 citations indexed

About

Jiří Masopust is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Neurology. According to data from OpenAlex, Jiří Masopust has authored 45 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 12 papers in Cardiology and Cardiovascular Medicine and 6 papers in Neurology. Recurrent topics in Jiří Masopust's work include Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jiří Masopust is often cited by papers focused on Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jiří Masopust collaborates with scholars based in Czechia, Malaysia and Canada. Jiří Masopust's co-authors include Radován Malý, Martin Vališ, Ladislav Hosák, Blanka Klímová, Martin Vališ, Ctirad Andrýs, Kamil Kuča, Aleš Urban, J Rádl and Pavel Mohr and has published in prestigious journals such as Scientific Reports, IEEE Access and Archives of Disease in Childhood.

In The Last Decade

Jiří Masopust

38 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiří Masopust Czechia 15 223 123 75 60 52 45 570
S. Welch Canada 8 86 0.4× 174 1.4× 87 1.2× 27 0.5× 117 2.3× 10 724
Roberta Roberti Italy 12 201 0.9× 52 0.4× 21 0.3× 28 0.5× 51 1.0× 31 455
Yannick Plétan France 13 163 0.7× 97 0.8× 45 0.6× 19 0.3× 69 1.3× 27 561
Vittorio Bocola Italy 9 302 1.4× 110 0.9× 34 0.5× 131 2.2× 159 3.1× 13 1000
Emer R. McGrath United States 17 198 0.9× 332 2.7× 62 0.8× 32 0.5× 113 2.2× 40 916
Kosuke Matsuzono Japan 11 120 0.5× 44 0.4× 18 0.2× 29 0.5× 92 1.8× 64 434
Janine Gronewold Germany 15 98 0.4× 230 1.9× 13 0.2× 66 1.1× 76 1.5× 45 722
J. Boas Denmark 11 181 0.8× 169 1.4× 34 0.5× 38 0.6× 20 0.4× 14 798
Ruey‐Tay Lin Taiwan 21 191 0.9× 252 2.0× 78 1.0× 131 2.2× 259 5.0× 69 1.4k

Countries citing papers authored by Jiří Masopust

Since Specialization
Citations

This map shows the geographic impact of Jiří Masopust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Masopust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Masopust more than expected).

Fields of papers citing papers by Jiří Masopust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Masopust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Masopust. The network helps show where Jiří Masopust may publish in the future.

Co-authorship network of co-authors of Jiří Masopust

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Masopust. A scholar is included among the top collaborators of Jiří Masopust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Masopust. Jiří Masopust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kopeček, Miloslav, Jiří Masopust, & Martin Anders. (2023). New trends in schizophrenia treatment. 24(3). 140–147.
2.
Mohr, Pavel, Jiří Masopust, & Miloslav Kopeček. (2022). Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?. Frontiers in Psychiatry. 12. 781946–781946. 24 indexed citations
3.
Masopust, Jiří, et al.. (2019). Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series. Frontiers in Psychiatry. 10. 330–330. 10 indexed citations
4.
Klímová, Blanka, Martin Vališ, Kamil Kuča, & Jiří Masopust. (2019). E-learning as valuable caregivers’ support for people with dementia – A systematic review. BMC Health Services Research. 19(1). 781–781. 24 indexed citations
5.
Masopust, Jiří, et al.. (2018). Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review. Neuropsychiatric Disease and Treatment. Volume 14. 1211–1220. 76 indexed citations
6.
Linhart, R., et al.. (2017). Earth's thermal radiation sensors for attitude determination systems of small satellites. Contributions of the Astronomical Observatory Skalnaté Pleso. 47(2). 157–164. 4 indexed citations
7.
Vališ, Martin, Jiří Masopust, Oldřich Vyšata, et al.. (2016). Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy. Neurotoxicity Research. 31(1). 162–168. 24 indexed citations
8.
Vališ, Martin, et al.. (2015). Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia. Neuropsychiatric Disease and Treatment. 11. 619–619. 25 indexed citations
9.
Masopust, Jiří, Pavel Mohr, Martin Anders, & Radovan Přikryl. (2014). Diagnostika a farmakoterapie ADHD v dospělosti. 15(3). 112–117.
10.
Vališ, Martin, et al.. (2014). Common yew intoxication: a case report. Journal of Medical Case Reports. 8(1). 4–4. 17 indexed citations
11.
Masopust, Jiří, et al.. (2012). The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders.. PubMed. 24(3). 307–13. 17 indexed citations
12.
Masopust, Jiří, et al.. (2011). Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry. 11(1). 2–2. 64 indexed citations
13.
Masopust, Jiří & Radován Malý. (2010). Prevence kardiovaskulárního rizika a diabetu u nemocných schizofrenií: využití internetu v praxi. 11(3). 130–134. 1 indexed citations
14.
Masopust, Jiří, et al.. (2009). Case study Impulse control disorder associated with dopaminergic therapy in Parkinson’s disease - a case report. 4(3). 3–4. 1 indexed citations
15.
Malý, Radován, et al.. (2008). Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry and Clinical Neurosciences. 62(1). 3–8. 51 indexed citations
16.
Malý, Radován, Jiří Masopust, Ladislav Hosák, & Aleš Urban. (2008). Four cases of venous thromboembolism associated with olanzapine. Psychiatry and Clinical Neurosciences. 63(1). 116–118. 18 indexed citations
17.
Masopust, Jiří, Radován Malý, Aleš Urban, Ladislav Hosák, & Eva Čermáková. (2006). Antipsychotic drugs as a risk factor for venous thromboembolism. International Journal of Psychiatry in Clinical Practice. 11(3). 246–249. 15 indexed citations
18.
Masopust, Jiří & Martin Vališ. (2005). Léčba psychických komplikací Parkinsonovy nemoci. 4(6). 254–258. 1 indexed citations
19.
Bell, D. G., J. Rutenfranz, Jan Vávra, et al.. (1989). A comparison of coronary risk factors in groups of trained and untrained adolescents. European Journal of Applied Physiology. 58(6). 577–582. 15 indexed citations
20.
Masopust, Jiří, et al.. (1964). [DIFFERENTIATION OF TYPES OF CONGENITAL METHEMOGLOBINEMIA].. PubMed. 19. 233–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Welch Breakdown of academic impact, for papers by Roberta Roberti Breakdown of academic impact, for papers by Yannick Plétan Breakdown of academic impact, for papers by Vittorio Bocola Breakdown of academic impact, for papers by Emer R. McGrath Breakdown of academic impact, for papers by Kosuke Matsuzono Breakdown of academic impact, for papers by Janine Gronewold Breakdown of academic impact, for papers by J. Boas Breakdown of academic impact, for papers by Ruey‐Tay Lin
Rankless by CCL
2026